TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/23/24 16:37 | 7/22/24 | HALO | Halozyme Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Labrosse Nicole | CA | O | SVP,CFO | S.d | -270 | 53.93 | 0 | -5 | -24 | 15 | D | ||||||||||||||
6/28/24 16:06 | 6/26/24 | HALO | Halozyme Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Labrosse Nicole | CA | O | SVP,CFO | S.dm | -1,558 | 51.93 | 0 | -30 | -66 | 15 | D | ||||||||||||||
2/21/23 19:00 | 2/16/23 | HALO | Halozyme Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Labrosse Nicole | CA | O | SVP,CFO | S.d | -124 | 49.26 | 0 | -3 | -22 | 9 | D | ||||||||||||||
11/16/22 19:51 | 11/15/22 | HALO | Halozyme Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Labrosse Nicole | CA | O | SVP,CFO | S | -269 | 53.81 | 0 | -5 | -55 | 4 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |